Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen

Breast cancer is one of the most common malignancies among woman. Decades of scientific study have linked the overexpression of ERBB2 antigen to aggressive tumors. To target aggressive breast cancer, chimeric antigen receptor (CAR) technology can be utilized. For this, human T-cells are transduced w...

Full description

Bibliographic Details
Main Authors: Munisvaradass, Rusheni, Ding, Shirley Suet Lee, Koh, Avin Ee Hwan, Subbiah, Suresh Kumar, Lim, Moon Nian, Vellasamy, Shalini, Abdullah, Syahril, Alarfaj, Abdullah A., Mok, Pooi Ling
Format: Article
Language:English
Published: Penerbit Universiti Kebangsaan Malaysia 2017
Online Access:http://psasir.upm.edu.my/id/eprint/60480/
http://psasir.upm.edu.my/id/eprint/60480/1/Overcoming%20the%20challenge%20of%20transduction%20of%20human%20T-cells%20with%20chimeric%20antigen%20receptor%20%28CAR%29%20specific%20for%20ERBB2%20antigen.pdf
_version_ 1848854206351409152
author Munisvaradass, Rusheni
Ding, Shirley Suet Lee
Koh, Avin Ee Hwan
Subbiah, Suresh Kumar
Lim, Moon Nian
Vellasamy, Shalini
Abdullah, Syahril
Alarfaj, Abdullah A.
Mok, Pooi Ling
author_facet Munisvaradass, Rusheni
Ding, Shirley Suet Lee
Koh, Avin Ee Hwan
Subbiah, Suresh Kumar
Lim, Moon Nian
Vellasamy, Shalini
Abdullah, Syahril
Alarfaj, Abdullah A.
Mok, Pooi Ling
author_sort Munisvaradass, Rusheni
building UPM Institutional Repository
collection Online Access
description Breast cancer is one of the most common malignancies among woman. Decades of scientific study have linked the overexpression of ERBB2 antigen to aggressive tumors. To target aggressive breast cancer, chimeric antigen receptor (CAR) technology can be utilized. For this, human T-cells are transduced with a gene sequence encoding a CAR that is specific for tumor-associated antigens (TAAs). These genetically-engineered CAR transduced T-cells (CAR-T cells) are able to target the tumor antigen without the need for major histocompatibility complex (MHC) recognition, rendering it a potentially universal immunotherapeutic option. However, efficient transduction of therapeutic gene into human T-cells and further cell expansion are challenging. In this study, we reported a successful optimization of a transduction protocol using spinoculation on CD3+ T-cells with different concentrations of lentiviral plasmid encoding the CAR gene. CD3+T-cells were isolated from the peripheral blood mononuclear cells (PBMCs). The constructed CAR gene was inserted into a lentiviral plasmid containing the green fluorescent protein (GFP) tag and lentiviral particles were produced. These lentiviral particles were used to transduce activated T-cells by spinoculation. T-cells were activated using Dynabead-conjugated CD3/CD28 human T-cell activator and interleukin-2 (IL-2) before transduction. CD3+ T-cells were selected and GFP expression, which indicated transduction, was observed. Future studies will focus on in vitro and in vivo models to determine the efficiency of CAR-T cells in specifically targeting ERBB2-expressing cells.
first_indexed 2025-11-15T11:06:11Z
format Article
id upm-60480
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T11:06:11Z
publishDate 2017
publisher Penerbit Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling upm-604802018-05-21T03:52:18Z http://psasir.upm.edu.my/id/eprint/60480/ Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen Munisvaradass, Rusheni Ding, Shirley Suet Lee Koh, Avin Ee Hwan Subbiah, Suresh Kumar Lim, Moon Nian Vellasamy, Shalini Abdullah, Syahril Alarfaj, Abdullah A. Mok, Pooi Ling Breast cancer is one of the most common malignancies among woman. Decades of scientific study have linked the overexpression of ERBB2 antigen to aggressive tumors. To target aggressive breast cancer, chimeric antigen receptor (CAR) technology can be utilized. For this, human T-cells are transduced with a gene sequence encoding a CAR that is specific for tumor-associated antigens (TAAs). These genetically-engineered CAR transduced T-cells (CAR-T cells) are able to target the tumor antigen without the need for major histocompatibility complex (MHC) recognition, rendering it a potentially universal immunotherapeutic option. However, efficient transduction of therapeutic gene into human T-cells and further cell expansion are challenging. In this study, we reported a successful optimization of a transduction protocol using spinoculation on CD3+ T-cells with different concentrations of lentiviral plasmid encoding the CAR gene. CD3+T-cells were isolated from the peripheral blood mononuclear cells (PBMCs). The constructed CAR gene was inserted into a lentiviral plasmid containing the green fluorescent protein (GFP) tag and lentiviral particles were produced. These lentiviral particles were used to transduce activated T-cells by spinoculation. T-cells were activated using Dynabead-conjugated CD3/CD28 human T-cell activator and interleukin-2 (IL-2) before transduction. CD3+ T-cells were selected and GFP expression, which indicated transduction, was observed. Future studies will focus on in vitro and in vivo models to determine the efficiency of CAR-T cells in specifically targeting ERBB2-expressing cells. Penerbit Universiti Kebangsaan Malaysia 2017 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/60480/1/Overcoming%20the%20challenge%20of%20transduction%20of%20human%20T-cells%20with%20chimeric%20antigen%20receptor%20%28CAR%29%20specific%20for%20ERBB2%20antigen.pdf Munisvaradass, Rusheni and Ding, Shirley Suet Lee and Koh, Avin Ee Hwan and Subbiah, Suresh Kumar and Lim, Moon Nian and Vellasamy, Shalini and Abdullah, Syahril and Alarfaj, Abdullah A. and Mok, Pooi Ling (2017) Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen. Sains Malaysiana, 46 (10). pp. 1831-1838. ISSN 0126-6039 http://www.ukm.my/jsm/english_journals/vol46num10_2017/contentsVol46num10_2017.html 10.17576/jsm-2017-4610-21
spellingShingle Munisvaradass, Rusheni
Ding, Shirley Suet Lee
Koh, Avin Ee Hwan
Subbiah, Suresh Kumar
Lim, Moon Nian
Vellasamy, Shalini
Abdullah, Syahril
Alarfaj, Abdullah A.
Mok, Pooi Ling
Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title_full Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title_fullStr Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title_full_unstemmed Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title_short Overcoming the challenge of transduction of human T-cells with chimeric antigen receptor (CAR) specific for ERBB2 antigen
title_sort overcoming the challenge of transduction of human t-cells with chimeric antigen receptor (car) specific for erbb2 antigen
url http://psasir.upm.edu.my/id/eprint/60480/
http://psasir.upm.edu.my/id/eprint/60480/
http://psasir.upm.edu.my/id/eprint/60480/
http://psasir.upm.edu.my/id/eprint/60480/1/Overcoming%20the%20challenge%20of%20transduction%20of%20human%20T-cells%20with%20chimeric%20antigen%20receptor%20%28CAR%29%20specific%20for%20ERBB2%20antigen.pdf